ArticleOphthalmology and therapy2025

Risk of Moderate to Severe Ocular Surface Disease Associated with Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Therapy: A Multicenter Cohort Study.

Yu-Ting Tsao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.